You have 9 free searches left this month | for more free features.

P1101, phase 1, healthy volunteers

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Participants Trial (PMN310, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Oct 26, 2023

Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

Recruiting
  • Systemic Amyloidosis
  • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
  • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 10, 2023

Healthy Subjects Trial in Melbourne (AP301)

Not yet recruiting
  • Healthy Subjects
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Oct 20, 2023

Hepatocellular Carcinoma Trial in Taipei city (P1101 (Ropeginterferon alfa-2b), Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Taipei city, Taiwan
    National Taiwan university Hospital
Jan 25, 2022

Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia Trial (VSA003, 0.9% NaCl)

Not yet recruiting
  • Dyslipidemias
  • +2 more
  • (no location specified)
May 9, 2023

Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)

Completed
  • Nonalcoholic Steatohepatitis
  • HUYPS-1 one tablet
  • HUYPS-1 nine tablets
  • Taipei, Taiwan
    Tri-Service General Hospital
Aug 1, 2023

Healthy Volunteer Trial in Lincoln (DISC-3405, Placebo)

Not yet recruiting
  • Healthy Volunteer
  • Lincoln, Nebraska
    Celerion
Sep 18, 2023

Essential Hypertension Trial in Seoul (L04RD1, L04TD3)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Aug 7, 2023

Healthy Trial in Adelaide (XH-S003 (A), Placebo (B))

Not yet recruiting
  • Healthy
  • XH-S003 (A)
  • Placebo (B)
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 21, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Healthy Adult Volunteers Trial in Beijing (VSA001 injection, Placebo)

Not yet recruiting
  • Healthy Adult Volunteers
  • VSA001 injection
  • Placebo
  • Beijing, Beijing, China
    Peking University Third Hospital
Feb 23, 2023

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

Healthy Volunteer Study Trial (Azelaprag)

Not yet recruiting
  • Healthy Volunteer Study
  • (no location specified)
Nov 15, 2023

Healthy Volunteers Trial in Secaucus (NRS-033, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • Secaucus, New Jersey
    Frontage Clinical Research Center
Feb 10, 2023

Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

Recruiting
  • Adrenocortical Carcinoma
  • 68Ga-R8760 injection at pre-defined dose levels
  • 68GA-R8760 injection
  • Ann Arbor, Michigan
    University of Michigan Nuclear Medicine
Aug 11, 2023

Healthy Trial in Seoul (L04RD1, L04TD1)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Jan 10, 2023

Healthy Volunteers Trial in Berlin (Zoliflodacin Patheon)

Recruiting
  • Healthy Volunteers
  • Zoliflodacin Patheon
  • Berlin, Germany
    Parexel Early Phase Clinical Unit
Nov 22, 2022

Healthy Trial in Seoul (L04RD1, L04TD2)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Jaewoo Kim
Jan 10, 2023

Healthy Volunteers Trial in Antwerpen (P03277 0.1 mmol/kg, Moxifloxacin 400mg, NaCl 0.9%)

Completed
  • Healthy Volunteers
  • P03277 0.1 mmol/kg
  • +3 more
  • Antwerpen, Belgium
    Clinical Pharmacology unit, SGS-Life Science Service
Mar 22, 2022

Healthy Trial in Seoul (ID120040002, Compound-X, Placebo comparator)

Recruiting
  • Healthy
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Dec 21, 2022

Healthy Volunteer Trial in Los Angeles (IRL201104, Placebo)

Recruiting
  • Healthy Volunteer
  • Los Angeles, California
    Revolo Phase I site
Jun 19, 2023

Amyotrophic Lateral Sclerosis Trial in Melbourne (SPG302, Placebo)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • Melbourne, Victoria, Australia
    Nucleus Melbourne
May 22, 2023

Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/1,000 mg)

Completed
  • Healthy
  • CT-L01 12.5/1,000 mg
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Healthy Adult Volunteers Trial in Adelaide (DR-0201, Placebo)

Not yet recruiting
  • Healthy Adult Volunteers
  • Adelaide, South Australia, Australia
    Dren Investigational Site
Aug 18, 2023